Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
Michael Bots, Inge Verbrugge, Benjamin P Martin, Jessica M Salmon, Margherita Ghisi, Adele Baker, Kym Stanley, Jake Shortt, Gert J Ossenkoppele, Johannes Zuber, Amy R Rappaport, Peter Atadja, Scott W Lowe, Ricky W Johnstone
Blood | AMER SOC HEMATOLOGY | Published : 2014
Awarded by Dutch Cancer Society
This work was supported by fellowships from the Dutch Cancer Society (AMC2009-4457) (M.B.) and (NKI2009-4446) (I.V.). R.W.J. is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and is supported by NHMRC Program and Project Grants, the Susan G. Komen Breast Cancer Foundation, Cancer Council Victoria, the Victorian Cancer Agency, and the Leukemia Foundation of Australia.